Atorvastatin Calcium Trihydrate (Crystalline/Amorphous) API
| Name of Product | Atorvastatin Calcium Trihydrate API |
|---|---|
| CAS No | 134523‑03‑8 |
| Therapeutic use:- | HMG‑CoA reductase inhibitor – lipid-lowering statin |
| Grade | USP/EP/BP/IP/IH |
| Form:- | API Powder |
| Status | Regular |
Product Overview
Atorvastatin Calcium Trihydrate can be crystalline or amorphous. It is part of the statin drug class.
It lowers blood lipid levels by inhibiting the HMG-CoA reductase enzyme. This product comes in crystalline and amorphous forms, ensuring versatile applications.
Therapeutic Applications
Controlling hypercholesterolemia is key. It lowers total cholesterol, LDL-C (bad cholesterol), and triglycerides effectively.
Reducing cardiovascular risk helps to prevent heart attacks, strokes, and related complications.
Mixed dyslipidemia, which corrects the lipid imbalances by increasing HDL-C (good cholesterol).
Preventive therapy is very useful for patients with diabetes.
Specification Parameters
The molecular weight is approximately 1209.42 g/mol.
CAS Number is 134523-03-8
Molecular formula C₆₆H₆₈CaF₂N₄O₁₀·3H₂O
Purity is ≥ 99% (typical pharmaceutical grade).
Atorvastatin calcium trihydrate is practically insoluble in water, but soluble in methanol, ethanol, and DMSO.
Packaging & Storage
Packaging is mainly done in fiber drums, aluminum foil-lined bags, and HDPE drums.
It has to be kept in tightly closed containers at a controlled room temperature.
Why Choose Us
Maintaining quality under GMP, ISO, and WHO-compliant manufacturing standards is our primary motive.
Offering reliable logistics support across Asia, Africa, Europe, and the Americas.
As per customer formulation, we are able to offer customization of the product.
We do have a proven track record and supply APIs to leading pharmaceutical companies.